Immunodiagnostic Systems Holdings Plc (IDH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 39,347 | 38,513 | 37,947 | 40,035 | 38,305 |
| Cost of Goods | 21,971 | 21,817 | 19,934 | 17,056 | 15,840 |
| Gross Profit | 17,376 | 16,696 | 18,013 | 22,979 | 22,465 |
| Operating Expenses | 16,048 | 16,356 | 16,551 | 19,924 | 20,676 |
| Operating Income | 1,328 | 340 | 1,462 | 3,055 | 1,789 |
| Interest Expense | 191 | 27 | 4 | 10 | 44 |
| Other Income | 2,117 | 529 | -523 | -1,854 | -38,768 |
| Pre-tax Income | 3,254 | 842 | 935 | 1,191 | -37,023 |
| Income Tax | -94 | 46 | -292 | -1,818 | -4,853 |
| Net Income Continuous | 3,348 | 796 | 1,227 | 3,009 | -32,170 |
| Net Income | $3,348 | $796 | $1,227 | $3,009 | $-32,170 |
| EPS Basic Total Ops | 0.12 | 0.03 | 0.04 | 0.10 | -1.10 |
| EPS Basic Continuous Ops | 0.12 | 0.03 | 0.04 | 0.10 | -1.10 |
| EPS Diluted Total Ops | 0.12 | 0.03 | 0.04 | 0.10 | -1.10 |
| EPS Diluted Continuous Ops | 0.12 | 0.03 | 0.04 | 0.10 | -1.10 |
| EBITDA(a) | $8,168 | $5,326 | $5,500 | $5,859 | $-29,996 |